Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/pharmacogenomics-and-placebo-response-in-a-randomized-clinical-trial-Jqh5bqnRv8
References (44)
-
V. Paschall (2001)
Long-Term Effects of Budesonide or Nedocromil in Children with AsthmaClinical Pediatrics, 40
-
L. Pappová, M. Jošková, I. Kazimierová, M. Šutovská, S. Fraňová (2016)
Combination Therapy with Budesonide and Salmeterol in Experimental Allergic Inflammation.Advances in experimental medicine and biology, 935
-
L. Colloca (2017)
Nocebo effects can make you feel painScience, 358
-
J. Krishnan, R. Lemanske, G. Canino, K. Elward, M. Kattan, E. Matsui, H. Mitchell, E. Sutherland, M. Minnicozzi (2012)
Asthma outcomes: symptoms.The Journal of allergy and clinical immunology, 129 3 Suppl
-
D. Carvalho-Silva, A. Pierleoni, M. Pignatelli, C. Ong, Luca Fumis, Nikiforos Karamanis, M. Carmona, Adam Faulconbridge, Andrew Hercules, Elaine McAuley, Alfredo Miranda, Gareth Peat, M. Spitzer, J. Barrett, D. Hulcoop, Eliseo Papa, Gautier Koscielny, I. Dunham (2018)
Open Targets Platform: new developments and updates two years onNucleic Acids Research, 47
-
Rui‐Sheng Wang, Kathryn Hall, Franco Giulianini, D. Passow, T. Kaptchuk, J. Loscalzo (2017)
Network analysis of the genomic basis of the placebo effect.JCI insight, 2 11
-
S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M. Ferreira, David Bender, J. Maller, P. Sklar, P. Bakker, M. Daly, P. Sham (2007)
PLINK: a tool set for whole-genome association and population-based linkage analyses.American journal of human genetics, 81 3
-
Sunita Sharma, D. Chhabra, A. Kho, L. Hayden, K. Tantisira, S. Weiss (2014)
The genomic origins of asthmaThorax, 69
-
J. Chan, A. Darke, K. Penney, C. Tangen, P. Goodman, G. Lee, T. Sun, Samuel Peisch, Alex Tinianow, J. Rae, E. Klein, I. Thompson, P. Kantoff, L. Mucci (2016)
Selenium- or Vitamin E–Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECTCancer Epidemiology, Biomarkers & Prevention, 25
-
J. Jiao, N. Meng, Luo Zhang (2014)
The Effect of Topical Corticosteroids, Topical Antihistamines, and Preservatives on Human Ciliary Beat FrequencyORL, 76
-
A. Sanders, E. Vrieze, A. Alazami, F. Alzahrani, Erik Malarkey, N. Sorusch, Lars Tebbe, S. Kuhns, Teunis Dam, Amal Alhashem, B. Tabarki, Q. Lu, N. Lambacher, Julie Kennedy, R. Bowie, L. Hetterschijt, S. Beersum, J. Reeuwijk, K. Boldt, H. Kremer, R. Kesterson, D. Monies, M. Abouelhoda, R. Roepman, Martijn Huynen, M. Ueffing, Rob Russell, U. Wolfrum, B. Yoder, E. Wijk, F. Alkuraya, O. Blacque (2015)
KIAA0556 is a novel ciliary basal body component mutated in Joubert syndromeGenome Biology, 16
-
T. Wager, L. Atlas (2015)
The neuroscience of placebo effects: connecting context, learning and healthNature Reviews Neuroscience, 16
-
Kathryn Hall, J. Buring, K. Mukamal, M. Moorthy, P. Wayne, T. Kaptchuk, E. Battinelli, P. Ridker, H. Sesso, S. Weinstein, D. Albanes, N. Cook, D. Chasman (2019)
COMT and Alpha-Tocopherol Effects in Cancer Prevention: Gene-Supplement Interactions in Two Randomized Clinical Trials.Journal of the National Cancer Institute
-
T. Maes, G. Joos, G. Brusselle (2012)
Targeting interleukin-4 in asthma: lost in translation?American journal of respiratory cell and molecular biology, 47 3
-
J. Tardif, É. Rhéaume, L. Perreault, J. Grégoire, Yassamin Zada, Géraldine Asselin, S. Provost, A. Barhdadi, D. Rhainds, P. L'allier, R. Ibrahim, R. Upmanyu, E. Niesor, R. Benghozi, G. Suchánková, F. Laghrissi-Thode, M. Guertin, A. Olsson, I. Mongrain, G. Schwartz, M. Dubé (2015)
Pharmacogenomic Determinants of the Cardiovascular Effects of DalcetrapibCirculation: Cardiovascular Genetics, 8
-
E. Forno, J. Lasky-Su, B. Himes, J. Howrylak, C. Ramsey, John Brehm, B. Klanderman, J. Ziniti, E. Mélen, G. Pershagen, M. Wickman, F. Martinez, D. Mauger, C. Sorkness, K. Tantisira, B. Raby, S. Weiss, J. Celedón (2012)
Genome-wide association study of the age of onset of childhood asthma.The Journal of allergy and clinical immunology, 130 1
-
Kathryn Hall, T. Kessler, J. Buring, D. Passow, H. Sesso, R. Zee, P. Ridker, D. Chasman, H. Schunkert (2019)
Genetic variation at the coronary artery disease risk locus GUCY1A3 modifies cardiovascular disease prevention effects of aspirin.European heart journal
-
J. Howick, R. Webster, N. Kirby, K. Hood (2018)
Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trialsTrials, 19
-
Kathryn Hall, C. Nelson, Roger Davis, J. Buring, I. Kirsch, M. Mittleman, J. Loscalzo, N. Samani, P. Ridker, T. Kaptchuk, D. Chasman (2014)
Polymorphisms in Catechol-O-Methyltransferase Modify Treatment Effects of Aspirin on Risk of Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 34
-
P. Foster, J. Mattes (2009)
IL‐21 comes of ageImmunology and Cell Biology, 87
-
Kathryn Hall, J. Loscalzo, T. Kaptchuk (2019)
Systems pharmacogenomics - gene, disease, drug and placebo interactions: a case study in COMT.Pharmacogenomics, 20 7
-
Kathryn Hall, Kathryn Hall, J. Kossowsky, J. Kossowsky, J. Kossowsky, T. Oberlander, T. Kaptchuk, T. Kaptchuk, J. Saul, V. Wyller, Even Fagermoen, Dag Sulheim, J. Gjerstad, Anette Winger, K. Mukamal, K. Mukamal (2016)
Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndromeThe pharmacogenomics journal, 16
-
T. Kaptchuk, F. Miller (2015)
Placebo Effects in Medicine.The New England journal of medicine, 373 1
-
S. Dutile, T. Kaptchuk, M. Wechsler (2014)
The Placebo Effect in AsthmaCurrent Allergy and Asthma Reports, 14
-
D. Chasman, D. Shiffman, R. Zee, Judy Louie, May Luke, C. Rowland, J. Catanese, J. Buring, J. Devlin, P. Ridker (2009)
Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy.Atherosclerosis, 203 2
-
L. Laitinen, A. Laitinen, A. Laitinen, T. Haahtela, T. Haahtela (1992)
A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial.The Journal of allergy and clinical immunology, 90 1
-
Christopher Chang, C. Chow, L. Tellier, S. Vattikuti, S. Purcell, James Lee (2014)
Second-generation PLINK: rising to the challenge of larger and richer datasetsGigaScience, 4
-
D. Finniss, T. Kaptchuk, F. Miller, F. Benedetti (2010)
Biological, clinical, and ethical advances of placebo effectsThe Lancet, 375
-
K. Hao, Y. Bossé, D. Nickle, P. Paré, D. Postma, M. Laviolette, A. Sandford, T. Hackett, D. Daley, J. Hogg, W. Elliott, C. Couture, M. Lamontagne, C. Brandsma, M. Berge, G. Koppelman, A. Reicin, D. Nicholson, V. Malkov, J. Derry, Christine Suver, J. Tsou, Amit Kulkarni, Chunsheng Zhang, R. Vessey, G. Opiteck, S. Curtis, W. Timens, D. Sin (2012)
Lung eQTLs to Help Reveal the Molecular Underpinnings of AsthmaPLoS Genetics, 8
-
M. Coleshill, L. Sharpe, L. Colloca, R. Zachariae, B. Colagiuri (2018)
Placebo and Active Treatment Additivity in Placebo Analgesia: Research to Date and Future Directions.International review of neurobiology, 139
-
R. Wise, S. Bartlett, Ellen Brown, M. Castro, R. Cohen, J. Holbrook, C. Irvin, C. Rand, M. Sockrider, E. Sugar (2009)
Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers.The Journal of allergy and clinical immunology, 124 3
-
M. Wechsler, J. Kelley, I. Boyd, S. Dutile, G. Marigowda, I. Kirsch, E. Israel, T. Kaptchuk (2011)
Active albuterol or placebo, sham acupuncture, or no intervention in asthma.The New England journal of medicine, 365 2
-
N. Khan, N. Willemarck, A. Talebi, A. Marchand, M. Binda, J. Dehairs, Natalia Rueda-Rincon, Veerle Daniels, Muralidhararao Bagadi, D. Raj, F. Vanderhoydonc, S. Munck, P. Chaltin, J. Swinnen (2016)
Identification of drugs that restore primary cilium expression in cancer cellsOncotarget, 7
-
Clinical efficacy, safety and tolerability of vr475 1 mg/2 ml twice daily given for 52 weeks -
W. Busse, S. Holgate, E. Kerwin, Y. Chon, J. Feng, Joseph Lin, Shao-Lee Lin (2013)
Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma.American journal of respiratory and critical care medicine, 188 11
-
Kathryn Hall, J. Loscalzo (2019)
Drug‐Placebo Additivity in Randomized Clinical TrialsClinical Pharmacology & Therapeutics, 106
-
D. Grelotti, T. Kaptchuk (2011)
Placebo by proxyThe BMJ, 343
-
T. Pers, P. Timshel, J. Hirschhorn (2015)
SNPsnap: a Web-based tool for identification and annotation of matched SNPsBioinformatics, 31 3
-
A. Brunoni, Mariana Lopes, T. Kaptchuk, F. Fregni (2009)
Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-AnalysisPLoS ONE, 4
-
Randall Pruim, R. Welch, Serena Sanna, Tanya Teslovich, Peter Chines, Terry Gliedt, M. Boehnke, G. Abecasis, Cristen Willer (2010)
LocusZoom: regional visualization of genome-wide association scan resultsBioinformatics, 26
-
I. Kirsch (2000)
Are drug and placebo effects in depression additive?Biological Psychiatry, 47
-
Sonali Patel, W. Stason, A. Legedza, S. Ock, T. Kaptchuk, L. Conboy, K. Canenguez, J. Park, E. Kelly, E. Jacobson, C. Kerr, A. Lembo (2005)
The placebo effect in irritable bowel syndrome trials: a meta‐analysis 1Neurogastroenterology & Motility, 17
-
Sayantani Das, L. Forer, S. Schönherr, C. Sidore, A. Locke, Alan Kwong, S. Vrieze, E. Chew, S. Levy, M. McGue, D. Schlessinger, D. Stambolian, Po-ru Loh, W. Iacono, A. Swaroop, L. Scott, F. Cucca, F. Kronenberg, M. Boehnke, G. Abecasis, C. Fuchsberger (2016)
Next-generation genotype imputation service and methodsNature Genetics, 48
-
R. Halwani, Asma Sultana, A. Vazquez-Tello, Amer Jamhawi, A. Al-Masri, S. Al‐Muhsen (2017)
Th-17 regulatory cytokines IL-21, IL-23, and IL-6 enhance neutrophil production of IL-17 cytokines during asthmaJournal of Asthma, 54
- Publisher
- Wiley
- Copyright
- © 2019 American Society for Clinical Pharmacology and Therapeutics
- ISSN
- 0009-9236
- eISSN
- 1532-6535
- DOI
- 10.1002/cpt.1646
- Publisher site
- See Article on Publisher Site
Abstract
Genetic variation may differentially modify drug and placebo treatment effects in randomized clinical trials. In asthma, although lung function and asthma control improvements are commonplace with placebo, pharmacogenomics of placebo vs. drug response remains unexamined. In a genomewide association study of subjective and objective outcomes with placebo treatment in Childhood Asthma Management Program of nedocromil/budesonide vs. placebo (N = 604), effect estimates for lead single nucleotide polymorphisms (SNPs) were compared across arms. The coughing/wheezing lead SNP, rs2392165 (β = 0.94; P = 1.10E‐07) mapped to BBS9, a gene implicated in lung development that contains a lung function expression quantitative trait locus. The effect was attenuated with budesonide (Pinteraction = 1.48E‐07), but not nedocromil (Pinteraction = 0.06). The lead forced vital capacity SNP, rs12930749 (β = −5.80; P = 1.47E‐06), mapped to KIAA0556, a locus genomewide associated with respiratory diseases. The rs12930749 effect was attenuated with budesonide (Pinteraction = 1.32E‐02) and nedocromil (Pinteraction = 1.09E‐02). Pharmacogenomic analysis revealed differential effects with placebo and drug treatment that could potentially guide precision drug development in asthma.
Journal
Clinical Pharmacology & Therapeutics – Wiley
Published: Dec 1, 2019